Table 1.
Patient Characteristics |
Total Cohort n = 242 |
CTRL n = 160 |
COMB n = 82 |
Significance p-Value |
---|---|---|---|---|
Age at first diagnosis, years, mean (SD) | 54.5 (14.2) | 54.7 (14.4) | 54.3 (13.7) | 0.84 |
Cancer entity, n (%) | 1.13 | |||
Breast, n (%) | 212 (87.6) | 136 (85) | 75 (91.5) | |
Ovarian, n (%) | 25 (10.3) | 19 (11.9) | 6 (7.3) | |
Other 1), n (%) | 5 (2.1) | 5 (3.1) | 0 (0) | |
UICC stage | 0.08 | |||
0 | 1 (0.4) | 1 (0.6) | 0 | |
I | 49 (20.2) | 26 (16.3) | 23 (28.0) | |
II | 86 (35.5) | 55 (34.4) | 31 (37.8) | |
III | 49 (20.2) | 39 (24.4) | 10 (12.2) | |
IV | 44 (18.2) | 29 (18.1) | 15 (18.3) | |
NA | 13 (5.4) | 10 (6.3) | 82 (3.7) |
Characteristics of the patients included in the study, total cohort and respective treatment groups; IQR, interquartile range, 1) other cancer entities include endometrium, tubal, vulva and cervical cancer; n, number; %, percent; UICC, Union for International Cancer Control.